請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/55991
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 賈景山(Jean-San Chia) | |
dc.contributor.author | Yi-Ru Chen | en |
dc.contributor.author | 陳怡如 | zh_TW |
dc.date.accessioned | 2021-06-16T05:12:27Z | - |
dc.date.available | 2019-10-09 | |
dc.date.copyright | 2014-10-09 | |
dc.date.issued | 2014 | |
dc.date.submitted | 2014-08-18 | |
dc.identifier.citation | Andrieu-Abadie., N., and Levade., T. (2002). Sphingomyelin hydrolysis during apoptosis. Biochim Biophys Acta 1585, 126-134.
Ao, Z.-H., Xu, Z.-H., Lu, Z.-M., Xu, H.-Y., Zhang, X.-M., and Dou, W.-F. (2009). Niuchangchih( Antrodia camphorata) and its potential in treating liver diseases. Journal of Ethnopharmacology 121, 194-212. Bensadoun, R.-J., Schubert, M.M., Lalla, R.V., and Keefe, D. (2006). Amifostine in the management of radiation-induced and chemo-induced mucositis. Supportive care in cancer 14, 566-572. Bensinger, W., Schubert, M., Ang, K.K., Brizel, D., Brown, E., Eilers, J.G., Elting, L., Mittal, B.B., Schattner, M.A., Spielberger, R., et al. (2008). NCCN Task Force Report. prevention and management of mucositis in cancer care. Journal of the National Comprehensive Cancer Network : JNCCN 6 Suppl 1, S1-21; quiz S22-24. Chang, T., and Chou, W. (1995). Antrodia cinnamomea sp. nov. on Cinnamomum kanehirai in Taiwan. Mycological Research 99, 756-758. Chen, C.-C., Liu, Y.-W., Ker, Y.-B., Wu, Y.-Y., Lai, E.Y., Chyau, C.-C., Hseu, T.-H., and Peng, R.Y. (2007). Chemical characterization and anti-inflammatory effect of polysaccharides fractionated from submerge-cultured Antrodia camphorata mycelia. Journal of agricultural and food chemistry 55, 5007-5012. Chen, C.-J., Su, C., and Lan, M. (2001). Study on solid cultivation and bioactivity of Antrodia camphorata. Fungal Sci 16, 65-72. Geethangili, M., and Tzeng, Y.-M. (2011). Review of pharmacological effects of Antrodia camphorata and its bioactive compounds. Evidence-Based Complementary and Alternative Medicine 2011. Grdina, D.J., Murley, J.S., Kataoka, Y., Baker, K.L., Kunnavakkam, R., Coleman, M.C., and Spitz, D.R. (2009). Amifostine induces antioxidant enzymatic activities in normal tissues and a transplantable tumor that can affect radiation response. International journal of radiation oncology, biology, physics 73, 886-896. Hensley, M.L., Hagerty, K.L., Kewalramani, T., Green, D.M., Meropol, N.J., Wasserman, T.H., Cohen, G.I., Emami, B., Gradishar, W.J., Mitchell, R.B., et al. (2009). American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27, 127-145. Hseu, Y.-C., Wu, F.-Y., Wu, J.-J., Chen, J.-Y., Chang, W.-H., Lu, F.-J., Lai, Y.-C., and Yang, H.-L. (2005). Anti-inflammatory potential of< i> Antrodia Camphorata</i> through inhibition of iNOS, COX-2 and cytokines via the NF-κB pathway. International immunopharmacology 5, 1914-1925. Hseu, Y.C., Chen, S.C., Yech, Y.J., Wang, L., and Yang, H.L. (2008). Antioxidant activity of Antrodia camphorata on free radical-induced endothelial cell damage. J Ethnopharmacol 118, 237-245. Huang, E.-Y., Leung, S.W., Wang, C.-J., Chen, H.-C., Sun, L.-M., Fang, F.-M., Yeh, S.-A., Hsu, H.-C., and Hsiung, C.-Y. (2000). Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial. International Journal of Radiation Oncology* Biology* Physics 46, 535-539. Karrow, N., McCay, J., Brown, R., Musgrove, D., Pettit, D., Munson, A., Germolec, D., and White Jr, K. (2000). Thalidomide stimulates splenic IgM antibody response and cytotoxic T lymphocyte activity and alters leukocyte subpopulation numbers in female B6C3F1 mice. Toxicology and applied pharmacology 165, 237-244. Keefe, D.M., Schubert, M.M., Elting, L.S., Sonis, S.T., Epstein, J.B., Raber-Durlacher, J.E., Migliorati, C.A., McGuire, D.B., Hutchins, R.D., Peterson, D.E., et al. (2007). Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109, 820-831. Kuo, M.-C., Chang, C.-Y., Cheng, T.-L., and Wu, M.-J. (2008). Immunomodulatory effect of Antrodia camphorata mycelia and culture filtrate. Journal of ethnopharmacology 120, 196-203. Lenz, W., Pfeiffer, R.A., Kosenow, W., and Hayman, D. (1962). Thalidomide and congenital abnormalities. The Lancet 279, 45-46. Liu, D.Z., Liang, H.J., Chen, C.H., Su, C.H., Lee, T.H., Huang, C.T., Hou, W.C., Lin, S.Y., Zhong, W.B., Lin, P.J., et al. (2007). Comparative anti-inflammatory characterization of wild fruiting body, liquid-state fermentation, and solid-state culture of Taiwanofungus camphoratus in microglia and the mechanism of its action. J Ethnopharmacol 113, 45-53. Lockhart, P.B., and Sonis, S.T. (1979). Relationship of oral complications to peripheral blood leukocyte and platelet counts in patients receiving cancer chemotherapy. Oral surgery, oral medicine, and oral pathology 48, 21-28. Lu, M.-K., Cheng, J.-J., Lai, W.-L., Lin, Y.-R., and Huang, N.-K. (2006). Adenosine as an active component of< i> Antrodia cinnamomea</i> that prevents rat PC12 cells from serum deprivation-induced apoptosis through the activation of adenosine A< sub> 2A</sub> receptors. Life sciences 79, 252-258. McBride, W.G. (1961). Thalidomide and congenital abnormalities. The Lancet 278, 1358. Moller, D.R., Wysocka, M., Greenlee, B.M., Ma, X., Wahl, L., Flockhart, D.A., Trinchieri, G., and Karp, C.L. (1997). Inhibition of IL-12 production by thalidomide. The Journal of Immunology 159, 5157-5161. Moreira, A., Sampaio, E.P., Zmuidzinas, A., Frindt, P., Smith, K.A., and Kaplan, G. (1993). Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. The Journal of experimental medicine 177, 1675-1680. Moreira, A.L., Friedlander, D.R., Shif, B., Kaplan, G., and Zagzag, D. (1999). Thalidomide and a thalidomide analogue inhibit endothelial cell proliferation in vitro. Journal of neuro-oncology 43, 109-114. Nightingale, S.L. (1997). From the food and drug administration. Jama 278, 805-805. Raber-Durlacher, J.E., Elad, S., and Barasch, A. (2010). Oral mucositis. Oral oncology 46, 452-456. Rao, Y.K., Fang, S.-H., and Tzeng, Y.-M. (2007). Evaluation of the anti-inflammatory and anti-proliferation tumoral cells activities of Antrodia camphorata, Cordyceps sinensis, and Cinnamomum osmophloeum</i> bark extracts. Journal of ethnopharmacology 114, 78-85. Schuler, U., and Ehninger, G. (1995). Thalidomide: rationale for renewed use in immunological disorders. Drug Safety 12, 364-369. Shen, Y.C., Chou, C.J., Wang, Y.H., Chen, C.F., Chou, Y.C., and Lu, M.K. (2004). Anti‐inflammatory activity of the extracts from mycelia of Antrodia camphorata cultured with water‐soluble fractions from five different Cinnamomum species. FEMS Microbiology Letters 231, 137-143. Sheskin, J. (1965). Thalidomide in the treatment of lepra reactions. Clinical pharmacology and therapeutics 6, 303. Sonis, S.T. (2002). The Biologic Role for Nuclear Factor-Kappab in Disease and Its Potential Involvement in Mucosal Injury Associated with Anti-Neoplastic Therapy. Critical Reviews in Oral Biology & Medicine 13, 380-389. Sonis, S.T. (2004a). A biological approach to mucositis. J Support Oncol. 2, 21-32 Sonis, S.T. (2004b). The pathobiology of mucositis. Nature reviews. Cancer 4, 277-284. Sonis, S.T. (2007). Pathobiology of oral mucositis novel insights and opportunities. J Support Oncol. 5(9 suppl 4), 3-11. Sonis, S.T. (2009). Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral oncology 45, 1015-1020. Sonis, S.T. (2010). New thoughts on the initiation of mucositis. Oral diseases 16, 597-600. Spielberger, R., Stiff, P., Bensinger, W., Gentile, T., Weisdorf, D., Kewalramani, T., Shea, T., Yanovich, S., Hansen, K., Noga, S., et al. (2004). Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers. New England Journal of Medicine 351, 2590-2598. Tsai, Z., and Liaw, S. (1985). The use and the effect of Ganoderma. Sheng-Yun Publishers, Inc., Taichung, 116-117. Wu, S.-H., and Ryvarden, L. (1997). Antrodia camphorata (' niu-chang-chih'), new combination of a medicinal fungus in Taiwan. BOTANICAL BULLETIN-ACADEMIA SINICA TAIPEI 38, 273-276. Yang, H.-L., Hseu, Y.-C., Chen, J.-Y., Yech, Y.-J., Lu, F.-J., Wang, H.-H., Lin, P.-S., and Wang, B.-C. (2006). Antrodia camphorata in submerged culture protects low density lipoproteins against oxidative modification. The American journal of Chinese medicine 34, 217-231. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/55991 | - |
dc.description.abstract | 頭頸癌病人接受放射線治療後,會產生一種常見的副作用口腔黏膜炎,指的是口腔黏膜發炎、紅腫、潰瘍等現象,而口腔和咽喉的神經十分敏感,發炎會十分疼痛,無法言語,吞嚥困難,嚴重時只能靠靜脈注射供應水份及營養,影響癌症治療的結果。Reactive oxygen species及細胞激素 IL-1β、TNF-α常見於口腔黏膜潰瘍組織中,證明口腔黏膜炎是一種發炎相關疾病,但目前對於口腔黏膜炎的治療和預防效果都十分有限。Antrodia camphorata牛樟芝為台灣特有的真菌,牛樟芝具有抗癌、抗氧化和抗發炎的作用。餵食牛樟芝可抑制照射放射線所引發IL-1β反應在先前本實驗室所建立放射線引發口腔黏膜炎小鼠模式中,推測牛樟芝在口腔黏膜炎中扮演保護角色。Thalidomide為免疫調節藥物,具有抗癌、抗血管生成和免疫調節的作用,主要是透過降低TNF-α生成,而達到調節細胞激素的生成作用。Glutamine是具有抗氧化、免疫調節、提供能量特性的一種必需胺基酸,常見商品名為速養療,當作病人的營養添加劑,當病人服用glutamine可顯著降低口腔黏膜炎的嚴重性。因此本實驗將評估牛樟芝、thalidomide、glutamine這三種藥物是否可改善放射線引發的口腔黏膜炎。首先測試牛樟芝細胞毒性分析;第二是進行動物模型,分別以不同萃取方法牛樟芝 AC1和AC2、thalidomide、glutamine等四種藥物,針對口腔黏膜潰瘍的部位進行局部水敷,療效之評估方式為老鼠體重、舌頭外觀、生存率、舌頭發炎區塊計量等;第三是牛樟芝的高效液相色譜法分析。結果顯示,在牛樟芝濃度100 μg/ml以上對於人類舌癌鱗狀細胞株SAS具有細胞毒性,然而在正常細胞人類角質細胞株HaCaT則沒有細胞毒性;動物模式中發現,AC1、thalidomide、AC2可以有效緩解放射線誘發的體重下降;就舌頭外觀來看,AC1、thalidomide、AC2能讓發炎反應提早開始復原;就生存率來看,AC1、thalidomide能夠提高老鼠的存活率;就發炎區塊來看,thalidomide能在第十二和十四天有效減低發炎區塊,AC2能在第十四天有效減低發炎區塊,而AC1能使發炎趨勢減少,反之glutamine不具有緩解口腔黏膜炎之效果;高效液相色譜法分析發現,牛樟芝會隨著放置的時間增加而降解,因此每一次實驗都以新鮮泡製進行,另外,所使用之敷料為濾紙和紗布料,HPLC結果顯示,濾紙和紗布所吸收的成分一樣。綜合以上結果,牛樟芝和thalidomide能夠提供保護作用,有效減低口腔黏膜炎的嚴重性。 | zh_TW |
dc.description.abstract | Oral mucositis (OM) is the most common side-effect of patients with head and neck cancer undergoing radiation therapy. OM induced painful and difficult swallowing often interferes the radiotherapy course of cancer. OM is an inflammation-associated disease due to reactive oxygen species and proinflammatory cytokine including IL-1β and TNF-α detected in mucositis tissue. However, clinical management has not efficiently prevented and treated OM. Antrodia camphorata (AC) is a unique medical fungus of Taiwan, and has anti-cancer, anti-oxidant and anti-inflammatory effects. Previously, oral administration of AC attenuated IL-1β response in radiation-induced oral mucositis (RIM) mouse model was established by our lab and we speculated AC plays a protective role in OM. Thalidomide is an immunomodulatory drug, which has anti-cancer, anti-angiogenic, immunomodulatory effects through its down-regulated effect on TNF-α. Glutamine is an anti-oxidant, with immune regulation, to provide the energy characteristics of the essential amino acids; the brand name is SYMPT-X Plain Glutamine as patient's nutritional additives. Oral administration of glutamine can significantly reduce severity of OM. Therefore, our specific aim is to evaluate the therapeutic effect of AC from two extraction methods, thalidomide and glutamine on RIM. Firstly, we test the cytotoxicity effect of AC in cell viability test. Secondly, we test the therapeutic effect in animal model. Finally, the ingredients of AC are analyzed by high performance liquid chromatography (HPLC). Our data discovered that higher concentration of AC had cytotoxic effects on human tongue squamous cell, SAS. In RIM, topical application of AC1, AC2 and thalidomide solution in mucositis site reduced radiation induced body weight loss and ulceration/redness in tongue. AC1 and thalidomide can improve mouse survival in RIM. But glutamine had no therapeutic effect. HPLC data showed the effects of AC degraded by the time passing; the ingredients in AC- absorbed filter paper and gauze are the same. In summary, out study found AC and thalidomide had therapeutic effect on radiation-induced mucositis. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T05:12:27Z (GMT). No. of bitstreams: 1 ntu-103-R01450013-1.pdf: 3659492 bytes, checksum: 66049729b3671fd004ba4201abfda037 (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | 第一章 文獻回顧 1
1.1 口腔黏膜炎簡介 1 1.1.1口腔黏膜之病理學 1 1.1.2 口腔黏膜炎之預防及治療指引 3 1.2 牛樟芝簡介 5 1.2.1 牛樟芝之成分分析 5 1.2.2 牛樟芝之生物活性研究 5 1.3 Thalidomide簡介 7 1.3.1 Thalidomide作用機轉 8 第二章 本實驗之實驗設計及目標 9 第三章 實驗材料與方法 10 3.1 細胞毒性分析(Cell viability test/MTT assay) 10 3.2實驗動物及分組 10 3.3藥物製備 11 3.4 放射線照射 12 3.5分析口腔黏膜炎與檢體採集之方法 13 3.6局部塗抹作用的實驗設計 13 3.7 統計方法 14 第四章 結果 15 第一部分 細胞毒性分析 15 第二部分 藥物局部作用在單次劑量25 Gy放射線所引發口腔黏膜炎中的治療作用 15 第三部分 高效液相色譜法(High performance liquid chromatography, HPLC)分析牛樟芝成分 20 第五章 討論 22 第六章 參考文獻 24 第七章 圖 31 圖 一、本實驗所使用之牛樟芝,為廠商提供的人工培養固態發酵類子實體 31 圖 二、 本實驗所採用台大醫院之醫用直線加速器 32 圖 三、放射線所引發口腔黏膜炎小鼠模式的實驗設計 33 圖 四、局部塗抹作用的實驗設計 34 圖 五、 牛樟芝的細胞毒性測試 35 圖 六、牛樟芝局部作用在放射線所引發口腔黏膜炎的老鼠體重變化 36 圖 七、牛樟芝局部作用在放射線所引發口腔黏膜炎的老鼠舌頭外觀 37 圖 八、牛樟芝局部作用在放射線所引發口腔黏膜炎的老鼠生存率 38 圖 九、牛樟芝局部作用在放射線所引發口腔黏膜炎的老鼠舌頭潰瘍部分 39 圖 十、牛樟芝與Thalidomide局部作用在放射線所引發口腔黏膜炎的老鼠體重變化 40 圖 十一、牛樟芝和Thalidomide局部作用在放射線所引發口腔黏膜炎的老鼠舌頭外觀 41 圖 十二、牛樟芝和Thalidomide局部作用在放射線所引發口腔黏膜炎的老鼠生存率 42 圖 十三、牛樟芝和Thalidomide局部作用在放射線所引發口腔黏膜炎的老鼠舌頭潰瘍部分 43 圖 十四、牛樟芝AC1和AC 2局部作用在放射線所引發口腔黏膜炎的老鼠體重變化 44 圖 十五、牛樟芝AC1和AC2局部作用在放射線所引發口腔黏膜炎的老鼠舌頭外觀 45 圖 十六、牛樟芝AC1和AC 2局部作用在放射線所引發口腔黏膜炎的老鼠生存率 46 圖 十七、牛樟芝AC1和AC2局部作用在放射線所引發口腔黏膜炎的老鼠舌頭潰瘍部分 47 圖 十八、牛樟芝、Thalidomide和Glutamine局部作用在放射線所引發口腔黏膜炎的老鼠體重變化 49 圖 十九、牛樟芝、Thalidomide和Glutamine局部作用在放射線所引發口腔黏膜炎的老鼠舌頭外觀 51 圖 二十、牛樟芝、Thalidomide和Glutamine局部作用在放射線所引發口腔黏膜炎的老鼠生存率 52 圖 二十一、牛樟芝、Thalidomide和Glutamine局部作用在放射線所引發口腔黏膜炎的老鼠舌頭潰瘍部分 53 圖 二十二、來自2012年牛樟芝粉末水萃取物之HPLC分析圖 54 圖 二十三、來自2014年萃取(2012該批牛樟芝粉末)水溶液之HPLC分析圖 55 圖 二十四、來自2014年牛樟芝粉末之水萃取物之HPLC分析圖 56 圖 二十五、濾紙浸泡牛樟芝水萃取物水溶液至隔天後之HPLC分析圖 57 圖 二十六、紗布浸泡牛樟芝水萃取物水溶液至隔天後之HPLC分析圖 58 | |
dc.language.iso | zh-TW | |
dc.title | 牛樟芝在放射線所引發口腔黏膜炎中的治療作用 | zh_TW |
dc.title | Therapeutic effects of Antrodia camphorata on radiation-induced oral mucositis | en |
dc.type | Thesis | |
dc.date.schoolyear | 102-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 成佳憲(Chia-Hsien Cheng),忻凌偉(Ling-Wei Hsin) | |
dc.subject.keyword | 口腔黏膜炎,牛樟芝, | zh_TW |
dc.subject.keyword | Oral mucositis,Antrodia camphorata, | en |
dc.relation.page | 58 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2014-08-19 | |
dc.contributor.author-college | 牙醫專業學院 | zh_TW |
dc.contributor.author-dept | 口腔生物科學研究所 | zh_TW |
顯示於系所單位: | 口腔生物科學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf 目前未授權公開取用 | 3.57 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。